Neuronal IκB Kinase β Protects Mice from Autoimmune Encephalomyelitis by Mediating Neuroprotective and Immunosuppressive Effects in the Central Nervous System
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Some aspects of CNS-directed autoimmunity in multiple sclerosis are modeled in mice by immunization with myelin Ags where tissue damage is driven by myelin-reactive Th1 and Th17 effector lymphocytes. Whether the CNS plays an active role in controlling such autoimmune diseases is unknown. We used mice in which IκB kinase β was deleted from Ca2+/calmodulin-dependent kinase IIα-expressing neurons (nIKKβKO) to investigate the contribution of neuronal NF-κB to the development of myelin oligodendrocyte glycoprotein 35–55-induced experimental autoimmune encephalomyelitis. We show that nIKKβKO mice developed a severe, nonresolving disease with increased axon loss compared with controls and this was associated with significantly reduced CNS production of neuroprotective factors (vascular endothelial growth factor, CSF1-R, and FLIP) and increased production of proinflammatory cytokines (IL-6, TNF, IL-12, IL-17, and CD30L) and chemokines. The isolation of CNS-infiltrating monocytes revealed greater numbers of CD4+ T cells, reduced numbers of NK1.1+ cells, and a selective accumulation of Th1 cells in nIKKβKO CNS from early in the disease. Our results show that neurons play an important role in determining the quality and outcome of CNS immune responses, specifically that neuronal IκB kinase β is required for neuroprotection, suppression of inflammation, limitation of Th1 lymphocyte accumulation, and enhancement of NK cell recruitment in experimental autoimmune encephalomyelitis-affected CNS and stress the importance of neuroprotective strategies for the treatment of multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724 · cited 1×
“Neuroprotection in MS would have a 2-fold benefit: first, because it would slow the neurodegenerative process which starts early in the disease and is probably a secondary consequence of inflammation (3, 5) and, second, because healthy neurons have immune-regulatory effects (6).”
BackgroundNF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614 · cited 2×
“VEGF is a NF- B-inducible gene (54) and is also responsive to HIF-1 which is NF- B dependent (21).”
BackgroundSelf-citationVEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017 · cited 1×
“To study the function of IKK in neurons during a chronic demyelinating and neurodegenerative disease, we used the MOG35–55EAE model for MS, which is characterized by a chronic nonrelapsing clinical course in C57BL/6 mice and shows neuronal damage and forebrain involvement (49).”
MethodNF-κB in neuronal plasticity and neurodegenerative disorders
Mattson, M. P., & Camandola, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11916 · Cited by 877 · cited 1×
“Thus, neuronal NF- B activity is necessary for TNF-induced neuroprotection against excitotoxic and ischemic injury, is central to ischemic tolerance, and protects mice against secondary lesion expansion following cerebral ischemia (52, 53).”
BackgroundEssential Role for TrkB Receptors in Hippocampus-Mediated Learning
Minichiello, L., Korte, M., Wolfer, D., Kühn, R., Unsicker, K., Cestari, V., Rossi-Arnaud, C., Lipp, H.-P., Bonhoeffer, T., & Klein, R. (1999) · Neuron · doi:10.1016/s0896-6273(00)80853-3 · Cited by 799
Neuronal ‘On’ and ‘Off’ signals control microglia
Biber, K., Neumann, H., Inoue, K., & Boddeke, H. W. G. M. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.08.007 · Cited by 787 · cited 1×
“The immune regulatory properties of neurons in the normal CNS have been addressed in several earlier studies (6, 65).”
BackgroundVascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia
Jin, K. L., Mao, X. O., & Greenberg, D. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10242 · Cited by 684
Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain
Brionne, T. C., Tesseur, I., Masliah, E., & Wyss-Coray, T. (2003) · Neuron · doi:10.1016/s0896-6273(03)00766-9 · Cited by 367
Constitutive Nuclear Factor-κB Activity Is Required for Central Neuron Survival
Bhakar, A. L., Tannis, L.-L., Zeindler, C., Russo, M. P., Jobin, C., Park, D. S., MacPherson, S., & Barker, P. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08466.2002 · Cited by 310
Fridmacher, V., Kaltschmidt, B., Goudeau, B., Ndiaye, D., Rossi, F. M., Pfeiffer, J., Kaltschmidt, C., Israël, A., & Mémet, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-28-09403.2003 · Cited by 167 · cited 1×
“CamkIICre mice have already been extensively characterized and used (29, 48) and we further characterized the pattern of Cre-mediated gene deletion in our system by crossing CamkIICre mice with the ROSA26 reporter strain which carries a loxP-flanked neo “stop” cassette within the coding sequence of -galactosidase gene…”
Method
Cited by
Astrocytes: Key Regulators of Neuroinflammation
Colombo, E., & Farina, C. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.06.006 · Cited by 904
Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF
Fischer, R., & Maier, O. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/610813 · Cited by 731
Microglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., Ladner, K. J., Bevan, A. K., Foust, K. D., Godbout, J. P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.013 · Cited by 638
“…inhibition of IKKb in neuronal cells utilizing a CamkII cre-driver experienced more severe EAE symptoms and succumb to disease earlier due to their inability to induce neuronal expression of NF-kB-dependent neuroprotective and antiapoptotic genes (Emmanouil et al., 2009; Taoufik et al., 2011).”
TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects
Probert, L. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.038 · Cited by 495
Self-citationInterleukin-6, a mental cytokine
Spooren, A., Kolmus, K., Laureys, G., Clinckers, R., De Keyser, J., Haegeman, G., & Gerlo, S. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.01.002 · Cited by 352
“On the other hand, neuronal deletion of the inhibitor of NF-κB kinase-β (IKK-β), an NF-κB-activating kinase, induces amore severe outcome of EAE, with enhanced expression of IL-6, concomitant with the upregulated expression of other pro-inflammatory genes (Emmanouil et al., 2009).”
Background
Metadata
- Authors
- Emmanouil, M., Taoufik, E., Tseveleki, V., Vamvakas, S.-S., Tselios, T., Karin, M., Lassmann, H., & Probert, L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12
- Volume
- 183
- Issue
- 12
- Pages
- 7877-7889
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2001393747
- Cited by
- 39
- References
- 12
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.